FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2301015949> ?p ?o ?g. }

• W2301015949 abstract "Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PAMitogen Activated Protein Kinase (MAPK) pathways initiate with external signaling, proceed through a sequence of protein kinases, and alter cell proliferation, growth, and survival. MAPK pathways proceed through a well-ordered sequence but are interconnected and modified by the cell's internal needs. The MEK-catalyzed phosphorylation of its target ERK represents the most selective interaction of MAPK signaling cascades. The type III MEK1/2 inhibitor, Mekinist, was recently approved by the FDA for the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations. This success suggests inhibitors of other MEK/ERK cascades may be reasonable strategies for anti-cancer therapeutic strategies. Despite the likely involvement of MEK5 phosphorylation of ERK5 in early and triple negative breast cancers, prostate cancer, and renal cancer, little work has been focused on developing selective MEK5 inhibitors. We have previously described an initial series of anthranilic acid derivatives structurally derived from the known non-selective MEK inhibitor PD0325901. To explore structural requirements for selective inhibition of MEK5 versus MEK1/2, aryl substitution and the role of proposed internal hydrogen bonding of the ligand were examined with novel compounds. These were tested at 10 μM in MDB-MB-213 cells subsequently treated with EGF to induce MEK1/2 and MEK5 phosphorylation. Western blot analysis following electrophoresis using IR-tagged antibodies raised against pERK1/2, pERK5, ERK1/2, or ERK5 permitted determination of total and relative inhibition of MEK-mediated generation of pERK. Incubation with PD0325901 resulted in full suppression of both pERK1/2 and pERK5. For the aryl substitutions examined, omission of the halogens on the pendant phenyl group (SC-1-181) abolished MEK1/2 inhibition(0% decrease in pERK1/2) yet retained good MEK5 inhibition (82% decrease in pERK5). Disruption of an internal nitrogen-acyl hydrogen bond preferentially decreased MEK5 inhibition (SC-2-32: 40% and 16% decrease in pERK5 and pERK1/2 respectively). This establishes early evidence of significant variation in specificity of MEK type III binding sites that may be exploited as pharmacological tools and possibly as therapeutic agents for cancers overexpressing MEK5.Citation Format: Patrick T. Flaherty, Jane C. Cavanaugh, Mohit Gupta, Colin Vechery, Suravi Chakrabarty, Darlene Monlish, Thomas Wright. Analysis of aryl substitution and intramolecular ligand H-bonding in selective inhibitors of the MEK5/ERK5 cascade. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1963. doi:10.1158/1538-7445.AM2015-1963" @default.
• W2301015949 created "2016-06-24" @default.
• W2301015949 creator A5020539295 @default.
• W2301015949 creator A5026020049 @default.
• W2301015949 creator A5049516951 @default.
• W2301015949 creator A5057334251 @default.
• W2301015949 creator A5067088371 @default.
• W2301015949 creator A5067914357 @default.
• W2301015949 creator A5076152468 @default.
• W2301015949 date "2015-08-01" @default.
• W2301015949 modified "2023-09-26" @default.
• W2301015949 title "Abstract 1963: Analysis of aryl substitution and intramolecular ligand H-bonding in selective inhibitors of the MEK5/ERK5 cascade" @default.
• W2301015949 doi "https://doi.org/10.1158/1538-7445.am2015-1963" @default.
• W2301015949 hasPublicationYear "2015" @default.
• W2301015949 type Work @default.
• W2301015949 sameAs 2301015949 @default.
• W2301015949 citedByCount "0" @default.
• W2301015949 crossrefType "proceedings-article" @default.
• W2301015949 hasAuthorship W2301015949A5020539295 @default.
• W2301015949 hasAuthorship W2301015949A5026020049 @default.
• W2301015949 hasAuthorship W2301015949A5049516951 @default.
• W2301015949 hasAuthorship W2301015949A5057334251 @default.
• W2301015949 hasAuthorship W2301015949A5067088371 @default.
• W2301015949 hasAuthorship W2301015949A5067914357 @default.
• W2301015949 hasAuthorship W2301015949A5076152468 @default.
• W2301015949 hasConcept C116569031 @default.
• W2301015949 hasConcept C11960822 @default.
• W2301015949 hasConcept C121608353 @default.
• W2301015949 hasConcept C126322002 @default.
• W2301015949 hasConcept C170493617 @default.
• W2301015949 hasConcept C184235292 @default.
• W2301015949 hasConcept C185592680 @default.
• W2301015949 hasConcept C2777658100 @default.
• W2301015949 hasConcept C2781249067 @default.
• W2301015949 hasConcept C502942594 @default.
• W2301015949 hasConcept C55493867 @default.
• W2301015949 hasConcept C57074206 @default.
• W2301015949 hasConcept C71924100 @default.
• W2301015949 hasConcept C97029542 @default.
• W2301015949 hasConceptScore W2301015949C116569031 @default.
• W2301015949 hasConceptScore W2301015949C11960822 @default.
• W2301015949 hasConceptScore W2301015949C121608353 @default.
• W2301015949 hasConceptScore W2301015949C126322002 @default.
• W2301015949 hasConceptScore W2301015949C170493617 @default.
• W2301015949 hasConceptScore W2301015949C184235292 @default.
• W2301015949 hasConceptScore W2301015949C185592680 @default.
• W2301015949 hasConceptScore W2301015949C2777658100 @default.
• W2301015949 hasConceptScore W2301015949C2781249067 @default.
• W2301015949 hasConceptScore W2301015949C502942594 @default.
• W2301015949 hasConceptScore W2301015949C55493867 @default.
• W2301015949 hasConceptScore W2301015949C57074206 @default.
• W2301015949 hasConceptScore W2301015949C71924100 @default.
• W2301015949 hasConceptScore W2301015949C97029542 @default.
• W2301015949 hasLocation W23010159491 @default.
• W2301015949 hasOpenAccess W2301015949 @default.
• W2301015949 hasPrimaryLocation W23010159491 @default.
• W2301015949 hasRelatedWork W1975857526 @default.
• W2301015949 hasRelatedWork W1980732218 @default.
• W2301015949 hasRelatedWork W1990414934 @default.
• W2301015949 hasRelatedWork W1999362712 @default.
• W2301015949 hasRelatedWork W2017821413 @default.
• W2301015949 hasRelatedWork W2021421610 @default.
• W2301015949 hasRelatedWork W2085724471 @default.
• W2301015949 hasRelatedWork W2096232104 @default.
• W2301015949 hasRelatedWork W2130887139 @default.
• W2301015949 hasRelatedWork W2213747091 @default.
• W2301015949 hasRelatedWork W2296289242 @default.
• W2301015949 hasRelatedWork W2323689180 @default.
• W2301015949 hasRelatedWork W2338761486 @default.
• W2301015949 hasRelatedWork W2416841295 @default.
• W2301015949 hasRelatedWork W2567767096 @default.
• W2301015949 hasRelatedWork W2728475625 @default.
• W2301015949 hasRelatedWork W3118287616 @default.
• W2301015949 hasRelatedWork W2186791415 @default.
• W2301015949 hasRelatedWork W2359680686 @default.
• W2301015949 hasRelatedWork W2740773651 @default.
• W2301015949 isParatext "false" @default.
• W2301015949 isRetracted "false" @default.
• W2301015949 magId "2301015949" @default.
• W2301015949 workType "article" @default.